Follow
Mark E. Issa
Mark E. Issa
Massachusetts General Hospital & Harvard Medical School
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes
MC Ernst, M Issa, KB Goralski, CJ Sinal
Endocrinology 151 (5), 1998-2007, 2010
3612010
Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma
ME Issa, FS Takhsha, CS Chirumamilla, C Perez-Novo, ...
Clinical Epigenetics 9, 1-13, 2017
822017
Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis
ME Issa, S Muruganandan, MC Ernst, SD Parlee, BA Zabel, EC Butcher, ...
American Journal of Physiology-Cell Physiology 302 (11), C1621-C1631, 2012
632012
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses
F Huang, C Gonçalves, M Bartish, J Rémy-Sarrazin, ME Issa, B Cordeiro, ...
The Journal of clinical investigation 131 (8), 2021
462021
Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells
ME Issa, SR Hall, SN Dupuis, CL Graham, DL Jakeman, KB Goralski
Anti-Cancer Drugs 25 (3), 255-269, 2014
372014
Cytotoxic flavonoids and other constituents from the stem bark of Ochna schweinfurthiana
JT Ndongo, ME Issa, AN Messi, J Ngo Mbing, M Cuendet, DE Pegnyemb, ...
Natural Product Research 29 (17), 1684-1687, 2015
362015
Bruceantin inhibits multiple myeloma cancer stem cell proliferation
ME Issa, S Berndt, G Carpentier, JM Pezzuto, M Cuendet
Cancer biology & therapy 17 (9), 966-975, 2016
342016
Hydroxyl ketone-based histone deacetylase inhibitors to gain insight into class I HDAC selectivity versus that of HDAC6
MDM Traoré, V Zwick, CA Simões-Pires, A Nurisso, M Issa, M Cuendet, ...
ACS omega 2 (4), 1550-1562, 2017
192017
Targeting multiple myeloma Cancer stem cells with natural products–lessons from other hematological malignancies
ME Issa, S Cretton, M Cuendet
Planta medica 83 (09), 752-760, 2017
182017
Withanolide D exhibits similar cytostatic effect in drug-resistant and drug-sensitive multiple myeloma cells
ME Issa, EMK Wijeratne, AAL Gunatilaka, M Cuendet
Frontiers in pharmacology 8, 281103, 2017
172017
Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cells
ME Issa, M Cuendet
MedChemComm 8 (1), 112-121, 2017
162017
A bivalent role of genistein in sprouting angiogenesis
S Berndt, ME Issa, G Carpentier, M Cuendet
Planta medica 84 (09/10), 653-661, 2018
112018
Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy
J Krueger, F Santinon, A Kazanova, ME Issa, B Larrivee, R Kremer, ...
PLoS One 16 (6), e0251731, 2021
102021
An observational study examining the effects of a surgically induced inflammatory response on the distribution of morphine and its metabolites into cerebrospinal fluid
DJ Roberts, J Wood, RI Hall
Canadian Journal of Anesthesia 64 (10), 1009, 2017
62017
Structure–Activity Relationships of Withanolides as Antiproliferative Agents for Multiple Myeloma: Comparison of Activity in 2D Models and a 3D Coculture Model
MF Freitas Misakyan, EMK Wijeratne, ME Issa, YM Xu, A Monteillier, ...
Journal of Natural Products 84 (8), 2321-2335, 2021
42021
Glycogen synthase kinase-3 (GSK-3) regulation of inhibitory coreceptor expression in T-cell immunity
ME Issa, CE Rudd
Journal of cellular immunology 3 (5), 336, 2021
22021
Surgery-induced inflammation reduces morphine distribution into cerebrospinal fluid
Y Wang
12014
The cytotoxic effects of novel jadomycins in drug-sensitive and drug-resistant MCF7 breast cancer cells
M Issa
12013
Characterization of the Expression and Function of Chemerin and CMKLR1 within the Central Nervous System
SD Parlee, WH Salih, ME Issa, KB Goralski
The FASEB Journal 22, 1166.5-1166.5, 2008
12008
Glioblastoma stem cell metabolism and immunity
J Hawly, M Murcar, A Schcolnik‑Cabrera, ME Issa
Cancer and Metastasis Reviews, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20